19 completed, 3 unknown, 2 not yet recruiting, 2 recruiting. 9 Not applicable, 7 Phase 4, 3 Phase 2, 2 Phase 1, 2 Phase 3.
Follow Atopic Eczema: new trials by email Literature Review of Atopic Eczema trials Research Report on Atopic Eczema
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate the Efficacy and Safety of MG-K10 in Participants Who Have Atopic Dermatitis MG-K10 Humanized Monoclonal Antibody Injection - Atopic Dermatitis, Atopic Eczema | Phase 3 | Not yet recruiting | Shanghai Mabgeek Biotech.Co.Ltd | 498 | 2026-05-01 | 2026-03-18 |
| Cutaneous Biomarkers in Atopic Eczema Using a Non-Invasive Micro-Suction Device in Babies Eczema, Atopic Dermatitis | Recruiting | King's College London | 30 | 2026-03-31 | 2026-08-05 | |
| Efficacy of Crisaborole 2% Cream Versus Placebo in Mild to Moderate Atopic Eczema Placebo Cream, Crisaborole 2% Cream - Atopic Dermatitis (AD), Atopic Eczema | Phase 4 | Not yet recruiting | Jinnah Postgraduate Medical Centre | 270 | 2026-03-01 | 2026-03-06 |
| Safety, Tolerability and PK of ATTO-3712 in Healthy Volunteers and Patients With Atopic Dermatitis ATTO-3712, Placebo - Normal Volunteers, Atopic Dermatitis (AD) | Phase 1 | Completed | Attovia Therapeutics Inc | 48 | 2025-10-22 | 2026-09-11 |
| Safety, Tolerability and PK of ATTO-1310 in Healthy Volunteers and Patients With Atopic Dermatitis and Patients With Chronic Pruritus ATTO-1310, ATTO-1310 Placebo - Normal Volunteers, Atopic Dermatitis (AD) | Phase 1 | Completed | Attovia Therapeutics Inc | 108 | 2025-01-14 | 2026-09-11 |
| A Study to Evaluate the Emollient Performance of Doublebase Once in the Treatment of Atopic Eczema Doublebase Once - Atopic Eczema | Not applicable | Recruiting | Dermal Laboratories Ltd | 65 | 2024-10-30 | 2025-03-18 |
| A Pilot Study of Efficacy and Safety of SIM05 in Adults With Atopic Eczema SIM05 - Atopic Eczema | Not applicable | Active not recruiting | Chinese University of Hong Kong | 30 | 2023-10-10 | 2025-03-28 |
| Dupilumab in Adolescent and Adult Skin of Color Participants: Open-label Moderate-to-severe Eczema Trial dupilumab, Topical emollient (moisturizer) - Moderate-to-Severe Atopic Dermatitis, Atopic Eczema | Phase 4 | Completed | Regeneron Pharmaceuticals | 124 | 2023-01-11 | 2026-05-27 |
| A Study to Evaluate Adex Gel in the Treatment of Atopic Eczema. ADEX Gel - Atopic Eczema | Not applicable | Completed | Dermal Laboratories Ltd | 60 | 2022-11-16 | 2024-05-17 |
| The Effects of Topical Corticosteroid Use on Insulin Sensitivity and Bone Turnover Betnovate, betamethasone dipropionate ointment 0.1% and placebo, Protopic, tacrolimus ointment 0.1% - Atopic Dermatitis, Atopic Eczema | Phase 4 | Completed | Jacob Thyssen | 36 | 2019-08-22 | 2021-04-28 |
| A Community-based Assessment of Skin Care, Allergies, and Eczema Participant choice of over-the-counter emollients: Vaseline, Vanicream, CeraVe Healing Ointment, CeraVe cream, Cetaphil cream - Atopic Dermatitis, Atopic Disorders | Not applicable | Completed | Oregon Health and Science University | 1260 | 2018-07-16 | 2025-08-15 |
| Softened Water for Eczema Prevention Pilot Trial Domestic ion-exchange water softener - Atopic Eczema | Not applicable | Unknown | King's College London | 80 | 2018-02-12 | 2018-02-19 |
| A Longitudinal Investigation of Skin Barrier Development From Birth and the Validation of Early Predictors of Atopic Eczema Risk: the Skin Testing for Atopic Eczema Risk (STAR) Study Skin Testing for Atopic eczema - Atopic Eczema | Unknown | Sheffield Teaching Hospitals NHS Foundation Trust | 180 | 2017-03-02 | 2023-04-18 | |
| Narrowband Ultraviolet B Versus Narrowband Ultraviolet B Plus Ultraviolet A1 for Atopic Eczema combined ultraviolet phototherapy (NB-UVB + UVA1) vs. NB-UVB monotherapy - Atopic Eczema | Not applicable | Completed | University of Dundee | 39 | 2016-08-01 | 2020-11-06 |
| Role of Anti-IgE in Severe Childhood Eczema Xolair, Placebo - Atopic Eczema, Atopic Dermatitis | Phase 4 | Completed | Guy's and St Thomas' NHS Foundation Trust | 62 | 2014-12-01 | 2019-08-09 |
| Evaluation of an Integrated Care Project Asthma, Allergic Rhinitis | Completed | Charite University, Berlin, Germany | 3960 | 2013-03-01 | 2019-02-15 | |
| Study to Investigate Skin Conditions and Patient Assessment of LAS 41002 in the Treatment of Atopic Eczema LAS 41002, Active - Atopic Eczema | Phase 2 | Completed | Almirall, S.A. | 20 | 2010-02-01 | 2010-07-12 |
| Comparison of Video-Based Versus Written Patient Education on Atopic Dermatitis Patient Educational Materials - Atopic Dermatitis, Atopic Eczema | Not applicable | Completed | University of California, Davis | 80 | 2009-01-01 | 2015-04-16 |
| Topical Treatment With Fresh Human Milk Versus Emollient on Atopic Eczema Spots in Young Children Human milk and emollient: Apobase creme® (Actavis Norway AS), Emollient: Apobase creme® (Actavis Norway AS) - Atopic Eczema | Not applicable | Completed | Oslo University Hospital | 9 | 2008-10-01 | 2015-03-06 |
| Regulatory T Cells (Tregs) in Polymorphic Light Eruption Polymorphic Light Eruption, Psoriasis | Completed | Medical University of Graz | 92 | 2008-03-01 | 2015-05-07 |
Showing 20 of 27. Sign in to see all of them.
Dermatitis, Atopic (27) · Eczema (4) · Pruritus (3) · Asthma (2) · Conjunctivitis, Allergic (1) · Depression (1) · Dermatitis (1) · Headache (1) · Hypersensitivity (1) · Migraine Disorders (1) · Psoriasis (1) · Rhinitis, Allergic (1) · Rhinitis, Allergic, Seasonal (1)
Congenital, Hereditary, and Neonatal Diseases and Abnormalities (27) · Genetic Diseases, Inborn (27) · Hypersensitivity, Immediate (27) · Immune System Diseases (27) · Skin Diseases (27) · Skin Diseases, Eczematous (27) · Skin Diseases, Genetic (27) · Skin and Connective Tissue Diseases (27) · Dermatitis (26) · Hypersensitivity (26) · Pathological Conditions, Signs and Symptoms (4) · Signs and Symptoms (4) · Skin Manifestations (3) · Bronchial Diseases (2) · Lung Diseases (2)
Betamethasone Valerate (2) · Omalizumab (2) · 5-methoxy-methylindoleacetic acid (1) · Emollients (1) · Exercise (1) · Milk, Human (1) · Skin Tests (1) · Tacrolimus (1) · Urea (1) · crisaborole (1) · dupilumab (1) · montelukast (1) · pimecrolimus (1) · pitrakinra (1)
ACO Hud Nordic AB (2) · Attovia Therapeutics Inc (2) · Dermal Laboratories Ltd (2) · King's College London (2) · Aerovance, Inc. (1) · Almirall, S.A. (1) · Charite University, Berlin, Germany (1) · Chinese University of Hong Kong (1) · Groningen Research Institute for Asthma and COPD (1) · Guy's and St Thomas' NHS Foundation Trust (1) · Jacob Thyssen (1) · Jinnah Postgraduate Medical Centre (1) · Medical University of Graz (1) · Novartis (1) · Oregon Health and Science University (1)
United Kingdom (8) · United States (5) · Germany (3) · Canada (2) · Sweden (2) · Austria (1) · Denmark (1) · Finland (1) · Hong Kong (1) · Netherlands (1) · New Zealand (1) · South Africa (1)
April Armstrong, MD (1) · Berit Berne, MD (1) · Carsten Flohr (1) · Carsten Flohr, PhD, FRCPCH (1) · Christoph Willers, MD, MBA (1) · Claudia M Witt, MD, MBA (1) · Darren Wilbraham, MBBS (1) · Eric J Duiverman, MD, PhD (1) · Eric Sicard, MD (1) · Eric Simpson, MD (1) · Jacob P Thyssen, Professor, MD, DMSc (1) · Jessica Ching, PhD (1) · Marianne L Brouwer, MD (1)
PMID 16839405, PMID 19127072, PMID 22948032, PMID 25935520, PMID 28330497, PMID 31434765, PMID 31764962, PMID 32131885, PMID 32933511, PMID 33006135, PMID 34854157, PMID 36824052, PMID 37926123, PMID 40699587, PMID 42126851
2009 (1), R01AR071057 (1)